Clopidogrel
Indication
Prevention of occlusive vascular events (NICE TA210)
MHRA Drug Safety Update - Clopidogrel: risk of acquired haemophilia
Green
Brand:
Nice TA:
210
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Cardiovascular system
Background
Recommendation
LSCMMG Recommendation:
Green
Reason for decision:
Suitable for initiation in primary care
Supporting documents: